Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 1 | |
Hold | 3 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 5 analysts offering 12 month price targets for Aclaris Therapeutics Inc have a median target of 7.00, with a high estimate of 13.00 and a low estimate of 3.00. The median estimate represents a 62.04% increase from the last price of 4.32.
High | 200.9% | 13.00 |
Med | 62.0% | 7.00 |
Low | -30.6% | 3.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate | -235.18% |
Average growth rate | +14.98% |
More ▼
Revenue history & estimates in USD
Average growth rate | +18.85% |
Average growth rate | +100.68% |
More ▼